Cong slams Yogi for campaigning in Karnataka after dust storm hits UP

Belagavi, 12: Even though the investigation into the four abandoned country pistols that were recovered by the Karnataka police on the outskirts of Waghawade village in Belagavi taluk last weekend did not make any headway, the police are verifying if the weapons had been used by the assassin of Gauri Lankesh for training.

Four country pistols were found abandoned on the outskirts of Waghawade on Sunday. Locals informed that the police had taken the weapons for inspection.

Prima facie it appeared that the weapons were rusted and had not been used for long. Cases had been registered against unidentified persons and investigations were in progress.

After reports that the weapons could have been used for training by the assassin of Gauri Lankesh in the forests in Khanapur, a few kilometres away from the spot wherein they were found, police have been looking into this angle too.

Sources said the condition of the weapons indicated that they have not been used for decades but to allay doubt all aspects were being looked into.

Bengaluru, Jun 6: Karnataka registered 378 Covid-19 cases in the past 24 hours, breaching the 5,000-mark to settle at 5,213, said an official, here on Saturday. "New cases reported from Friday 5 p.m. to Saturday 6 p.m. is 378," said a health official.

Of the new cases, 333 are local returnees, comprising 88 per cent of the new infections. Returnees from Maharashtra accounted for 99 per cent new cases at 329.

Majority infections in Karnataka nowadays are returnees, mostly from the state''s northern neighbour. Only 27 new infections were contacts of earlier cases.

On Saturday, cases spiked in Udupi, Kalaburagi, Yadgir, Bengaluru Urban, Belagavi, Vijayapura, Davangere and Dakshina Kannada.

Udupi witnessed the highest number of cases (121), followed by Yadgir (103), Kalaburagi (69), Dakshina Kannada (24), Bengaluru Urban (18), Vijayapura and Davangere (6 each), Belagavi (5), Gadag (4), Mandya, Hassan, Dharwad and Haveri (3 each), Raichur, Chikkaballapura and Uttara Kannada (2 each) and Bidar, Tumkur, Kolar and Koppal (1 each).

Among the new cases, three patients from Bengaluru Urban are suffering from Influenza Like Illness (ILI) and another from Severe Acute Respiratory Infection (SARI).

There were seven cases with international travel history to United Arab Emirates (UAE) and one to Turkey.

Meanwhile, 280 people were discharged in the past 24 hours and two persons succumbed to the virus, one from Bidar and another from Vijayapura. Of all the cases, 3,184 are active, 1,968 discharged, 59 dead and 11 in the ICU.

In the past 24 hours, Karnataka tested 11,862 people, of which 11,431 reports returned negative. In total, 3.72 lakh samples have been tested so far, of which 3.61 lakh have returned negative.

Currently, Udupi is leading the state''s Covid-19 burden with 785 active cases, followed by Kalaburagi (448), Yadgir (407), Raichur (320) and Mandya (163) among others.

Bengaluru Urban has accounted for 13 deaths, followed by Kalaburagi (7), Bidar, Vijayapura, Davangere and Dakshina Kannada (6 each) and Chikkaballapura (3 each), among others.

University of Oxford researchers have claimed that a cheap and widely available drug called dexamethasone can help save the lives of patients who are seriously ill with coronavirus.

Scientists working on the Recovery Trial found the drug could help patients on ventilators and oxygen, but had no effect on those who did not need help breathing.

“Based on these results, one death would be prevented by treatment of around eight ventilated patients or around 25 patients requiring oxygen alone,” researchers said in a statement.

Matt Hancock, the health secretary, tweeted: “This global first exemplifies the power of science.”

“I’m absolutely delighted that today we can announce the first successful clinical trial for a treatment for Covid-19,” Mr Hancock said.

Recovery Trial experts said a randomised group of 2,104 patients was given 6mg of dexamethasone per day for 10 days, while another group of 4,321 were given normal treatment.

Dexamethasone reduced deaths by one-fifth in patients on oxygen feeds and by one-third in those who needed a ventilator to breathe, preliminary results showed.

Mr Hancock added: “This is a huge step forward and it’s because we’ve backed the science.”

Martin Landray, professor of medicine and epidemiology at the Nuffield Department of Population Health, University of Oxford, and one of the trial’s chief investigators, said in a statement: “These preliminary results from the Recovery Trial are very clear – dexamethasone reduces the risk of death among patients with severe respiratory complications.

“Covid-19 is a global disease – it is fantastic that the first treatment demonstrated to reduce mortality is one that is instantly available and affordable worldwide.”